Tag:
Duke University
Latest Headlines
Latest Headlines
Mothers' breast milk may carry HIV fighting tool
Duke University scientists have uncovered another tool that they think will help defeat the HIV virus: antibodies in breast milk.
Non-stem cell treatment rebuilds heart muscle in a mouse
Scientists at Duke University used microRNAs to convert fibroblasts/scar tissue into heart muscle cells in a mouse, boosting the heart's ability to do its job.
Duke seeks IT fixes to research tampering after Potti probe
Duke University's medical school is taking action to prevent people from tampering with research data.
Scientists harness molecular 'transporter' to boost drug delivery prowess
Scientists have decoded the structure of a transporter molecule, and think they can design more targeted chemotherapy and anti-viral drugs that the molecule will recognize and carry to a tumor, without hurting healthy tissue.
HIV envelope protein approach elicits vaccine immune response
By focusing on HIV's envelope protein and targeting immature B cells--which the virus homes in on--researchers have found a new approach for potential vax candidates. The researchers--from Duke
NYT: Duke Univ. scandal shed light on flawed multi-gene cancer test
The New York Times has a story today that paints a damning portrait of life sciences researchers and companies that are rushing toward market with molecular tests for cancer before the tests have
Duke geneticist resigns over alleged research misconduct
Recent trouble over alleged research misconduct at Duke University has led to the resignation of geneticist Anil Potti. "He accepted full responsibility for a series of anomalies in data handling,
Duke researchers to test mosaic HIV vax candidate
Duke University researchers are assembling an international team to design the first human trial of a mosaic HIV vaccine candidate. Unlike traditional HIV vaccines that are designed to stimulate the
Promising glioblastoma data spur Celldex shares
Shares of Celldex Therapeutics shot up after a team of top researchers achieved prominent attention for some impressive mid-stage clinical trial results for a new therapeutic vaccine designed to
Regado garners $40M Series D for clotting tech
Regado Biosciences has pulled together a $40 million Series D round to push the development of a new technology designed to give doctors better control over blood clots. Edmond de Rothschild
